Document:

Second Amended and Restated Advisory

 Exhibit 10.1 
 SECOND AMENDMENT TO ADVISORY AGREEMENT 
 THIS SECOND AMENDMENT TO
ADVISORY AGREEMENT (this “Amendment”) is made and entered into as of the 20th day of March, 2013, by and among CNL HEALTHCARE PROPERTIES, INC., a corporation organized under the laws of the State of Maryland f/k/a CNL Healthcare
Trust, Inc. (the “Company”), CHP PARTNERS, LP, a limited partnership organized under the laws of the State of Delaware f/k/a CHT Partners, LP (the “Operating Partnership”), and CNL HEALTHCARE CORP., a corporation
organized under the laws of the state of Florida f/k/a CNL Properties Corp. (“Advisor”). 
 RECITALS

 WHEREAS, the Company, the Operating Partnership and the Advisor entered into that certain Advisory Agreement dated as
of June 8, 2011, as amended by that certain First Amendment to Advisory Agreement by and among the Company, the Operating Partnership and the Advisor, dated as of October 5, 2011 (the “Advisory Agreement”); and 

WHEREAS, capitalized terms not defined herein shall have the meaning given to such terms in the Advisory Agreement; and 

WHEREAS, the parties desire to enter into this Amendment for the purpose of amending certain provisions of the Advisory Agreement as more
particularly set forth herein. 
 NOW, THEREFORE, for and in consideration of the foregoing and other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows: 
 1.
Recitals. The recitals set forth above are true and correct and constitute a part of this Amendment. 
 2.
Restatement of Duties of the Advisor. Sections (3)(e) and (3)(g) of the Advisory Agreement are hereby amended and restated in their entirety to read as follows: 

(3) “(e) subject to the provisions of Sections 3(g) and 4 hereof (i) locate, analyze and select potential investments;
(ii) structure and negotiate the terms and conditions of transactions pursuant to which investments will be made; (iii) make investments on behalf of the Company and the Operating Partnership in compliance with the investment objectives
and policies of the Company; (iv) arrange for financing and refinancing and make other changes in the asset or capital structure of, and dispose of, reinvest the proceeds from the sale of, or otherwise deal with the investments; (v) enter
into leases and service contracts for Real Property; (vi) perform all other operational functions for the maintenance and administration of Company Property; and (vii) make dispositions of any portion of a Real Property to any Person other
than the Advisor, a Director or their Affiliates without obtaining the prior approval of the Board, provided such portion of a Real Property is sold, transferred or conveyed for a purchase price in an amount not to exceed One Million and No/100
Dollars ($1,000,000);” 
 “(g) obtain the prior approval of the Board, any particular Directors specified by the Board
or any committee of the Board, as the case may be, for any and all investments in and dispositions of Real Properties (except, with respect to dispositions, as expressly permitted in 3(e)(vii) above);” 

 3. Restatement of Asset Management Fee. Section (9)(a) of the Advisory Agreement
is hereby amended and restated in its entirety to read as follows: 
 “(9)(a) Asset Management Fee. The Company or
the Operating Partnership shall pay to the Advisor as compensation for the advisory services rendered to the Company and the Operating Partnership a monthly fee of an amount equal to 0.08334% of the monthly average of the sum of the Company’s
and the Operating Partnership’s respective daily Real Estate Asset Value (without duplication), plus the outstanding principal amount of any Loans made, plus the amount invested in Permitted Investments (excluding Real Estate Related Securities
and other Securities), and a monthly fee of an amount equal to 0.1042% of the monthly average on the daily book value of Real Estate Related Securities and other Securities, (the “Asset Management Fee”). The Asset Management Fee
shall be payable monthly on the first business day following the last day of such month. The Asset Management Fee shall not exceed fees which are competitive for similar services in the same geographic area, and may or may not be taken, in whole or
in part as to any year, in the sole discretion of the Advisor. All or any portion of the Asset Management Fee not taken as to any fiscal year shall be deferred without interest and may be taken in such other fiscal year as the Advisor shall
determine.” 
 4. Addition of Non-Solicitation Provision. The following provision is hereby added to and deemed
included in the Advisory Agreement in its entirety as Section (33) thereof: 
 “(33) Non-Solicitation. During
the period commencing on the date hereof and ending one year following the termination of this Agreement, the Company and the Operating Partnership shall not, without the Advisor’s prior written consent, directly or indirectly, (a) solicit
or encourage any person to leave the employment or other service of the Advisor, or (b) hire, on behalf of the Company, the Operating Partnership or any other person or entity, any person who has left the employment within the one year period
following the termination of that person’s employment with respect to the Advisor. During the period commencing on the date hereof through and ending one year following the termination of this Agreement, the Company and the Operating
Partnership will not, whether for its own account or for the account of any other person, firm, corporation, or other business organization, intentionally interfere with the relationship of the Advisor with, or endeavor to entice away from the
Advisor, any person who during the term of the Agreement is, or during the preceding one-year period, was a tenant, co-investor, co-developer, joint venturer, or other customer of the Advisor.” 

5. Binding Effect. This Amendment shall be binding upon, and inure to the benefit of, the parties hereto and their respective
successors and assigns. 
 6. Modification/Amendment. This Amendment may only be amended and modified in a writing signed
by all of the parties hereto. 
 7. Execution of Amendment. A party may deliver executed signature pages to this
Amendment by facsimile or electronic copy, which facsimile or electronic copy shall be deemed to be an original executed signature page. This Amendment may be executed in any number of counterparts, each of which shall be deemed to be an original
and all of which counterparts together shall constitute one agreement with the same effect as if the parties hereto had signed the same signature page. 

 8. Ratification. The terms and provisions in the Advisory Agreement are deemed
amended if and to the extent inconsistent with the terms of this Amendment. Otherwise, the terms and the provisions in the Advisory Agreement are hereby ratified and confirmed by the parties hereto. Except as modified herein, all other terms and
conditions of the Advisory Agreement shall continue in full force and effect. 
 IN WITNESS WHEREOF, the parties have executed
this Amendment as of the date first written above. 
  

							
	CNL HEATHCARE PROPERTIES, INC., a Maryland corporation
		
	By:	 	 /S/ STEPHEN H. MAULDIN

	Name:	 	 Stephen H. Mauldin

	Title:	 	 President

	
	CNL HEALTHCARE CORP., a Florida corporation
		
	By:	 	 /S/ THOMAS K. SITTEMA

	Name:	 	 Thomas K. Sittema

	Title:	 	 Chief Executive Officer

	
	CHP PARTNERS, LP, a
	Delaware limited partnership
		
	By:	 	CHP GP, LLC, a Delaware limited liability company, its general partner
			
		 	By:	 	CNL Healthcare Properties, Inc., a Maryland corporation, managing member of general partner
				
		 		 	By:	 	 /S/ STEPHEN H. MAULDIN

		 		 	Name:	 	 Stephen H. Mauldin

		 		 	Title:	 	 PresidentExpense Support and Conditional Reimbursement Agreement

 Exhibit 10.2 
 Expense Support and Restricted Stock Agreement 
 This Expense Support and
Restricted Stock Agreement (this “Agreement”), is made effective as of April 1, 2013 (the “Commencement Date”) by and among CNL Healthcare Properties, Inc. (the “Company”) and CNL Healthcare Corp. (the
“Advisor”). 
 WHEREAS, the Company maintains on file with the U. S. Securities and Exchange Commission an
effective registration statement on S-11 (File No. 333-168129), and amendments thereto, covering the continuous offering and sale of the Company’s common stock pursuant to the Securities Act of 1933, as amended (the “Registration
Statement”); and 
 WHEREAS, the Company and the Advisor have entered into an Advisory Agreement dated as of
June 8, 2011, as amended by a First Amendment to Advisory Agreement dated as of October 5, 2011, as further amended by a Second Amendment to Advisory Agreement dated as of March 20, 2013 (collectively, the “Advisory
Agreement”); and 
 WHEREAS, the Company is a REIT and, similar to other REITs, monitors its modified funds from
operations, and has incurred, and continues to incur a certain level of operating expenses; and 
 WHEREAS, the Company
and the Advisor have determined that it is appropriate and in the best interests of the Company to reduce its operating expenses relative to its invested assets. 
 NOW THEREFORE, in consideration of the premises and the mutual agreements herein contained, and for other good and valuable consideration (the receipt and sufficiency of which are hereby
acknowledged), the parties hereto agree as follows: 
 Note: Capitalized terms not otherwise defined herein have the meaning ascribed to them in
the Advisory Agreement. 
  

	1)	Expense Support. Beginning on the Commencement Date and continuing until terminated as provided herein, the Advisor shall provide expense support to the Company
through forgoing the payment of fees in cash and acceptance of restricted stock for services as provided herein, in an amount equal to the positive excess, if any, of (a) aggregate stockholder cash distributions declared for the applicable
quarter, over (b) the Company’s aggregate modified funds from operations, as defined below, for the same period (the “Expense Support Amount”). The Expense Support Amount shall be determined for each calendar quarter of the
Company, on a non-cumulative basis, with each such quarter-end date, a “Determination Date”. The Expense Support Amount will be credited by the Advisor to the Company in satisfaction of Asset Management Fees and other fees and expenses
owed to the Advisor under the Advisory Agreement, at the Advisor’s discretion. For purposes of this Agreement, modified funds from operations (“MFFO”) shall have the same meaning as such term is defined in the Company’s Form 10Q
and Form 10K as filed pursuant to the Securities Exchange Act of 1934, as amended. 

  

	2)	 Grant of Restricted Stock. In exchange for services rendered under the Advisory Agreement and in consideration of the expense support provided
by the Advisor as set forth in Section 1, the Company shall issue to the Advisor, within forty-five (45) days following each Determination Date, a number of shares of Common Stock (the “Restricted Stock”) equal to

	 	
the quotient of the Expense Support Amount for the preceding quarter divided by the then-current public offering price per share of Common Stock, on the terms and conditions and subject to the
restrictions set forth in this Agreement. 

  

	3)	Restricted Period; Vesting. Except as otherwise provided herein, the Restricted Stock will vest immediately prior to or upon the occurrence of a Liquidity Event
in which the Company’s stockholders will receive (i) total Distributions in an amount equal to 100% of Invested Capital, and (ii) an amount sufficient to pay the Stockholders a Priority Return (the “Vesting Threshold”). The
period between the Commencement Date and the date of the Liquidity Event is referred to as the “Restricted Period”. Prior to the occurrence of the Liquidity Event, the Board shall determine whether the Vesting Threshold is anticipated to
be met and whether the Restricted Stock will be forfeited or will vest, and upon such determination the Restricted Stock will immediately and permanently vest, or be immediately and permanently forfeited. In all cases the Restricted Stock will
either vest or be forfeited prior to the declaration of a Distribution related to the Liquidity Event. If the Restricted Stock does not vest after the Restricted Period, the Restricted Stock shall be immediately and permanently forfeited.

  

	4)	Termination of Advisory Agreement: In the event the Advisory Agreement is terminated without Cause by the Company, during the Restricted Period, the Restricted
Stock will vest upon termination (the “Termination Date”) if the Board of Director’s most recent estimated net asset value (“NAV”) per share of Common Stock plus total Distributions received by Stockholders prior to the
Termination Date is equal to or greater than the Vesting Threshold as calculated through the Termination Date. If the Board of Directors has not conducted an evaluation of the Company’s NAV per share of Common Stock as of the Termination Date,
or if the Vesting Threshold is not met as aforesaid, the Restricted Stock shall be immediately and permanently forfeited. If the Restricted Stock does not vest at the Termination Date pursuant to this section 4, the Restricted Stock shall be
immediately and permanently forfeited. If the Company terminates the Advisory Agreement for Cause during the Restricted Period, the Restricted Stock shall be immediately and permanently forfeited. If the Advisor terminates the Advisory Agreement
during the Restricted Period, the Restricted Stock shall be immediately and permanently forfeited. 

  

	5)	Restrictions. Subject to any exceptions set forth in this Agreement or the Plan, during the Restricted Period, the Restricted Stock or the rights relating
thereto may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Advisor. Any attempt to assign, alienate, pledge, attach, sell or otherwise transfer or encumber the Restricted Stock or the rights
relating thereto during the Restricted Period shall be wholly ineffective and, if any such attempt is made, the Restricted Stock will be forfeited by the Advisor and all of the Advisor’s rights to such shares shall immediately terminate without
any payment or consideration by the Company. 

	6)	Rights as Stockholder; Dividends. 

  

	 	a)	The Advisor shall be the record owner of the Restricted Stock until the shares of Common Stock are sold or otherwise disposed of, and shall be entitled to all of the
rights of a stockholder of the Company including, without limitation, the right to vote such shares (to the extent permitted by the Articles) and receive all dividends and other distributions paid with respect to such shares. All dividends or other
distributions actually paid to the Advisor in connection with the Restricted Stock shall vest immediately and will not be subject to forfeiture. 

  

	 	b)	The Company may issue stock certificates or evidence the Advisor’s interest by using a restricted book entry account with the Company’s transfer agent.
Physical possession or custody of any stock certificates that are issued shall be retained by the Company until such time as the Restricted Stock represented by such stock certificates vests. 

 

	 	c)	If the Restricted Stock is forfeited in accordance with Sections 3, 4 or 5 of this Agreement, the Advisor shall, on the date of such forfeiture, no longer have any
rights as a stockholder with respect to the Restricted Stock and shall no longer be entitled to vote or receive dividends or other distributions on such shares. 

 

	7)	REIT Status. The parties acknowledge and agree not to take any action that would impact the Company’s ability to qualify as a REIT, and further agree to
amend this agreement if necessary to allow the Company to continue to qualify as a REIT. 

  

	8)	Term and Termination of Agreement. This Agreement shall remain in effect until December 31, 2013, unless otherwise terminated pursuant to this
Section 8. This Agreement may be terminated by either party upon thirty (30) days prior written notice to the other party. This Agreement shall automatically terminate in the event of (a) the termination by the Company of the Advisory
Agreement or (b) the dissolution or liquidation of the Company. 

  

	9)	Headings. The captions of this Agreement are included for convenience only and in no way define or limit any of the provisions hereof or otherwise affect their
construction or effect. 

  

	10)	Interpretation. This Agreement shall be governed by and construed in accordance with the laws of the State of Florida (without reference to its conflicts of laws
provisions). 

  

	11)	Severability. If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of this Agreement
shall not be affected thereby and, to this extent, the provisions of this Agreement shall be deemed to be severable. 

  

	12)	Entire Agreement. This Agreement embodies the entire agreement and understanding of the parties hereto, and supersedes all prior agreements or understandings
(whether written or oral), with respect to the subject matter hereof. 

	13)	Amendments and Counterparts. This Agreement may only be amended by mutual written consent of the parties. This Agreement may be executed in any number of
counterparts, each of which shall be deemed to be an original, and all such counterparts shall, together, constitute only one instrument. 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be signed by their respective officers thereunto duly authorized, as of the day and year first above written. 

 

			
	CNL HEALTHCARE PROPERTIES, INC.
		
	By:	 	 /s/ Stephen H. Mauldin

	Name:	 	Stephen H. Mauldin
	Title:	 	Chief Executive Officer
	
	CNL HEALTHCARE CORP.
		
	By:	 	 /s/ Robert A. Bourne

	Name:	 	Robert A. Bourne
	Title:	 	Vice Chairman

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}]]